GM mosquitoes: inside the lab breeding six-legged agents in the war on malaria

TruthLens AI Suggested Headline:

"Oxitec Develops Genetically Modified Mosquitoes to Combat Malaria in Djibouti"

View Raw Article Source (External Link)
Raw Article Publish Date:
AI Analysis Average Score: 7.3
These scores (0-10 scale) are generated by Truthlens AI's analysis, assessing the article's objectivity, accuracy, and transparency. Higher scores indicate better alignment with journalistic standards. Hover over chart points for metric details.

TruthLens AI Summary

In a laboratory located on an industrial estate near Oxford, Michal Bilski, a research and development team leader at the biotechnology company Oxitec, is engaged in the intricate process of creating genetically modified (GM) mosquitoes. Bilski meticulously injects a DNA solution into mosquito eggs, a task that can take up to half an hour for each slide containing 50 to 100 eggs. The aim of this research is to produce GM mosquitoes that can significantly contribute to combating diseases such as malaria, dengue fever, Zika, and chikungunya, all of which are transmitted by mosquitoes. In a recent initiative, Oxitec released thousands of GM mosquitoes in Djibouti, marking a critical step in addressing the resurgence of malaria linked to an invasive mosquito species. Lottie Renwick, head of strategy at Malaria No More UK, emphasizes the potential of these GM mosquitoes to be a game-changer in malaria transmission reduction, although she stresses the importance of complementing this approach with other preventive measures like mosquito nets and vaccinations.

Malaria remains a severe global health challenge, particularly in Africa, where it accounted for 94% of the estimated 263 million cases and 597,000 deaths in 2023, with children under five being disproportionately affected. The invasive Anopheles stephensi mosquito, which is capable of thriving in urban areas and resistant to many insecticides, poses a significant threat to malaria control efforts across the continent. Djibouti, which had previously made strides toward eliminating malaria, saw a dramatic increase in cases due to this invasive species. The partnership between the Djibouti government and Oxitec aims to leverage GM mosquito technology to tackle this growing threat effectively. The laboratory process involves nurturing the injected eggs in controlled conditions until they hatch, while the resulting mosquitoes carry a self-limiting gene designed to reduce the population of female mosquitoes that transmit malaria. Despite the promising technology, Oxitec's CEO, Grey Frandsen, acknowledges the complexity of malaria transmission and the need for sustained efforts and funding from international donors to combat this public health crisis effectively.

TruthLens AI Analysis

The article delves into the innovative efforts being made to combat malaria through the use of genetically modified mosquitoes. It highlights the work of Michal Bilski and his team at Oxitec, who are at the forefront of this groundbreaking research. The narrative not only focuses on the technical aspects of mosquito modification but also emphasizes the broader implications for public health, particularly in regions where malaria is prevalent.

Motivation Behind the Publication

The aim of this article appears to be to raise awareness about the potential benefits of genetically modified organisms (GMOs) in addressing significant public health challenges like malaria. By showcasing the scientific process and the potential impact of GM mosquitoes, the article seeks to generate public interest and support for such biotechnological interventions.

Perception Management

The article contributes to a narrative that positions GM mosquitoes as a promising solution to a critical health crisis. By quoting experts who express optimism about the effectiveness of this approach, the article fosters a sense of hope and urgency around the fight against malaria, which disproportionately affects vulnerable populations, especially children in Africa.

Potential Concealments

While the article is informative, it does not delve into potential controversies surrounding genetic modification, such as ecological risks, ethical considerations, or public skepticism regarding GMOs. The omission of these elements may indicate a desire to present a more favorable view of GM mosquitoes without addressing the complexities and debates that accompany such technologies.

Manipulative Elements

The overall tone of the article is optimistic, focusing on the positive outcomes that GM mosquitoes could bring. However, the framing of scientists and organizations as primarily benevolent actors might overlook the multifaceted challenges and potential drawbacks of genetic modification. This could be seen as a manipulation of public perception, steering it towards acceptance without a thorough exploration of the risks involved.

Trustworthiness of the Information

The article appears credible, drawing from specific examples and expert opinions. However, its selective focus on the potential benefits of GM mosquitoes while downplaying the risks may affect its overall reliability. Readers should approach the information with a critical mindset, acknowledging both the scientific advancements and the ongoing debates within the field of biotechnology.

Community Support

The narrative is likely to resonate with health advocacy groups, environmentalists, and scientific communities that support innovative solutions to combat diseases. It may also appeal to policymakers seeking effective strategies to address public health challenges in developing regions.

Economic and Political Implications

Should GM mosquitoes prove effective, this development could lead to significant reductions in malaria cases, impacting healthcare costs and economic productivity in affected regions. Politically, it may influence discussions surrounding public health funding and biotechnological research.

Global Power Dynamics

The fight against malaria is not only a health issue but also a matter of global equity. The article underscores the need for innovative solutions in under-resourced areas, reflecting broader discussions on international health policy and resource allocation.

Artificial Intelligence Usage

There may be a possibility that AI tools were employed in compiling data or generating specific sections of the article. However, it is difficult to ascertain the extent of AI influence without explicit indicators. If AI were involved, it could have helped streamline the presentation of scientific information while maintaining a persuasive tone.

Manipulation Potential

The article could intentionally or unintentionally lead to a manipulation of public understanding by not fully addressing the complexities surrounding GMOs. The narrative leans towards optimism, which could shape public opinion favorably towards biotechnological interventions without a balanced discussion of potential drawbacks.

In conclusion, while the article presents valuable insights into the development of GM mosquitoes, it selectively emphasizes positive aspects and may downplay risks and complexities, impacting its overall reliability. Readers should remain aware of the broader context and ongoing debates regarding genetic modification.

Unanalyzed Article Content

In an unassuming building on an industrial estate outside Oxford, Michal Bilski sits in a windowless room with electric fly swatters and sticky tape on the wall, peering down a microscope. On the slide before him is a line of mosquito eggs that he collected less than an hour previously and put into position with a brush.

Bilski manoeuvres a small needle filled with a DNA concoction and uses it to pierce each egg and inject a tiny amount.

“Each slide has between 50 and 100 eggs on it, and it takes from 15 minutes to half an hour to inject them all,” he says. “Normally in a day we would inject between 500 to over 1,000 eggs.”

Bilski, a research and development team leader for the biotechnology company Oxitec, is carrying out one of the early stages in the process of making genetically modified (GM) mosquitoes.

It is hoped the insects that hatch will prove instrumental in the fight against diseases such as malaria,denguefever,Zikaandchikungunyaof which mosquitoes are vectors.

Last year, Oxitec released tens of thousands ofGM mosquitoes in Djibouti, where there has been a resurgence of malaria caused by an invasive species. It was the first time such mosquitoes have been released in east Africa and the second time on the continent.

It follows multiplereleases of modified mosquitoes in FloridaandBrazil to combat dengue fever, a neglected tropical disease.

The impact of these mosquitoes on malaria transmission could be significant, believes Lottie Renwick, head of strategy forMalariaNo More UK. “They will play a really major role and be gamechanging,” she says, but adds that the intervention needs to work alongside other tools such as mosquito nets and injections.

Malaria is transmitted by female mosquitoes and is one of the biggest killers of children under five. According to the World Health Organization, in 2023 there were an estimated263m cases of malaria and 597,000 deathsin 83 countries.

Africa bears the greatest burden (94% of cases) and children under five accounted for more than three-quarters (76%) of all malaria deaths.

Djibouti, an east African country of a million people, had been close to eliminating the disease, butcases jumped from just 27 in 2012 to more than 73,000 in 2020. The cause was a species of mosquito that came from south Asia and the Arabian peninsula into Africa.

TheAnopheles stephensimosquito has since been detected in Ethiopia, Sudan, Somalia and Kenya, as well as Nigeria and Ghana in west Africa.According to one study, if this mosquito is left unchecked an additional 126 million people on the continent will be at risk of malaria.

It is a big threat because it thrives in urban environments, unlike other malaria-carrying mosquitoes in Africa that primarily breed in rural areas. Cities in Africa are growing rapidly, with more thanhalf of Africans predicted to be urban dwellers by 2035.

Anopheles stephensihas also been found to be resistant to many of the insecticides used to control mosquito populations. They bite in the evening before most people’s bedtime – not in the middle of the night like other mosquitoes – making bed nets less effective as protection.

The government of Djibouti – aware of the work to develop and deploy GM mosquitoes to fight invasive species that spread dengue fever in Brazil – has partnered with Oxitec to tackle the threat.

In the laboratory, once every egg has been injected with the DNA, they are taken to a warm and humid room in which the conditions are ripe for them to mature into adults.

Sign up toGlobal Dispatch

Get a different world view with a roundup of the best news, features and pictures, curated by our global development team

after newsletter promotion

White shelves line the walls; on one side of the room are trays of water with mosquito larvae in them, while on the adjacent wall are plastic boxes filled with fully grown insects. One box has a contraption containing blood on top for the female mosquitoes to feed on. Inside the box the mosquitoes’ bottoms are pointing up, a sign that these insects carry the parasite that causes malaria.

It takes four or five days for the 5-30% of the eggs that usually survive the injection to hatch into larvae. In total, an egg typically takes about 14 days to develop into an adult mosquito.

In another room a few doors down, Anna Schoenauer, a team leader, is also glued to a microscope. When she shines blue light on the slide, a group of mosquitoes, magnified on a screen, can be seen wriggling around, glowing fluorescent green. This is as a result of a marker that they were injected with alongside the DNA, to signify whether they are carrying the altered gene.

The lab-produced mosquitoes carry a “self-limiting” gene that blocks normal cellular processes, which means if they mate, any female offspring will die. The male progeny, which do not bite, will survive and go on to mate with other wild females. With sustained releases of these “friendly mosquitoes”, more females die off, greatly reducing the mosquito population and the spread of malaria.

Scientists at Oxitec and malaria and mosquito experts insist these mosquitoes are safe. After evaluating the risk, theUS Food and Drug Administration in 2016and the USEnvironmental Protection Agency in 2022confirmed that the mosquitoes did not pose a threat to humans or the environment.

There are no results published yet from the work going on in Djibouti, and Grey Frandsen, chief executive officer at Oxitec, acknowledges that much work remains to be done.

“We’re working on the invasive species but there are multiple species that transmit malaria,” he says. “There is no silver bullet in the malaria fight.”

Currently, most of the funding going into technologies such as this comes from international donors and philanthropists. With the Trump administration’sshutdown of USAID, the landscape for international humanitarian work has changed, but Frandsen is undeterred.

“We recognise what’s happening, and the impact it might be having on the international health community, but this is our time to shine,” he says.

“This is when disruptive tools are needed the most. This is where new technologies have to now play a more important role than ever.”

Back to Home
Source: The Guardian